Clinical Trial Update: A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating MM-141 in patients with advanced solid tumors has completed enrollment. Hepatocellular carcinoma is listed among the conditions studied…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• MM-141

Snippet

Sponsor: Merrimack Pharmaceuticals | Conditions: Hepatocellular Carcinoma | Phase 1 | Status: COMPLETED